Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Polydatin Incorporated in Polycaprolactone Nanofibers Improves Osteogenic Differentiation

S. Lama, A. Luce, G. Bitti, P. Chacon-Millan, A. Itro, P. Ferranti, G. D'Auria, M. Cammarota, GF. Nicoletti, GA. Ferraro, C. Schiraldi, M. Caraglia, E. Amler, P. Stiuso

. 2022 ; 15 (6) : . [pub] 20220608

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22017006

Polycaprolactone nanofibers are used as scaffolds in the field of tissue engineering for tissue regeneration or drug delivery. Polycaprolactone (PCL) is a biodegradable hydrophobic polyester used to obtain implantable nanostructures, which are clinically applicable due to their biological safety. Polydatin (PD), a glycosidic precursor of resveratrol, is known for its antioxidant, antitumor, antiosteoporotic, and bone regeneration activities. We aimed to use the osteogenic capacity of polydatin to create a biomimetic innovative and patented scaffold consisting of PCL-PD for bone tissue engineering. Both osteosarcoma cells (Saos-2) and mesenchymal stem cells (MSCs) were used to test the in vitro cytocompatibility of the PD-PCL scaffold. Reverse-phase (RP) HPLC was used to evaluate the timing release of PD from the PCL-PD nanofibers and the MTT assay, scanning electron microscopy, and alkaline phosphatase (ALP) activity were used to evaluate the proliferation, adhesion, and cellular differentiation in both osteosarcoma and human mesenchymal stem cells (MSCs) seeded on PD-PCL nanofibers. The proliferation of osteosarcoma cells (Saos-2) on the PD-PCL scaffold decreased when compared to cells grown on PLC nanofibers, whereas the proliferation of MSCs was comparable in both PCL and PD-PCL nanofibers. Noteworthy, after 14 days, the ALP activity was higher in both Saos-2 cells and MSCs cultivated on PD-PCL than on empty scaffolds. Moreover, the same cells showed a spindle-shaped morphology after 14 days when grown on PD-PCL as shown by SEM. In conclusion, we provide evidence that nanofibers appropriately coated with PD support the adhesion and promote the osteogenic differentiation of both human osteosarcoma cells and MSCs.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22017006
003      
CZ-PrNML
005      
20220720100051.0
007      
ta
008      
220718s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/ph15060727 $2 doi
035    __
$a (PubMed)35745646
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Lama, Stefania $u Department of Precision Medicine, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy $1 https://orcid.org/0000000299721291
245    10
$a Polydatin Incorporated in Polycaprolactone Nanofibers Improves Osteogenic Differentiation / $c S. Lama, A. Luce, G. Bitti, P. Chacon-Millan, A. Itro, P. Ferranti, G. D'Auria, M. Cammarota, GF. Nicoletti, GA. Ferraro, C. Schiraldi, M. Caraglia, E. Amler, P. Stiuso
520    9_
$a Polycaprolactone nanofibers are used as scaffolds in the field of tissue engineering for tissue regeneration or drug delivery. Polycaprolactone (PCL) is a biodegradable hydrophobic polyester used to obtain implantable nanostructures, which are clinically applicable due to their biological safety. Polydatin (PD), a glycosidic precursor of resveratrol, is known for its antioxidant, antitumor, antiosteoporotic, and bone regeneration activities. We aimed to use the osteogenic capacity of polydatin to create a biomimetic innovative and patented scaffold consisting of PCL-PD for bone tissue engineering. Both osteosarcoma cells (Saos-2) and mesenchymal stem cells (MSCs) were used to test the in vitro cytocompatibility of the PD-PCL scaffold. Reverse-phase (RP) HPLC was used to evaluate the timing release of PD from the PCL-PD nanofibers and the MTT assay, scanning electron microscopy, and alkaline phosphatase (ALP) activity were used to evaluate the proliferation, adhesion, and cellular differentiation in both osteosarcoma and human mesenchymal stem cells (MSCs) seeded on PD-PCL nanofibers. The proliferation of osteosarcoma cells (Saos-2) on the PD-PCL scaffold decreased when compared to cells grown on PLC nanofibers, whereas the proliferation of MSCs was comparable in both PCL and PD-PCL nanofibers. Noteworthy, after 14 days, the ALP activity was higher in both Saos-2 cells and MSCs cultivated on PD-PCL than on empty scaffolds. Moreover, the same cells showed a spindle-shaped morphology after 14 days when grown on PD-PCL as shown by SEM. In conclusion, we provide evidence that nanofibers appropriately coated with PD support the adhesion and promote the osteogenic differentiation of both human osteosarcoma cells and MSCs.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Luce, Amalia $u Department of Precision Medicine, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy $1 https://orcid.org/0000000303726870
700    1_
$a Bitti, Giuseppe $u Institute of Biophysics, 2nd Faculty of Medicine, Charles University, V Uvalu 84, 15006 Prague, Czech Republic
700    1_
$a Chacon-Millan, Pilar $u Department of Precision Medicine, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy
700    1_
$a Itro, Annalisa $u Plastic Surgery Unit, Department of Multidisciplinary Medical and Dental Specialties, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy
700    1_
$a Ferranti, Pasquale $u Department of Agricultural Sciences, University of Naples Federico II, 80138 Portici, Italy
700    1_
$a D'Auria, Giovanni $u Department of Agricultural Sciences, University of Naples Federico II, 80138 Portici, Italy $1 https://orcid.org/0000000293863256
700    1_
$a Cammarota, Marcella $u Department of Experimental Medicine, Section of Biotechnology, Molecular Medicine and Medical Histology, University of Campania "L. Vanvitelli", 80138 Naples, Italy
700    1_
$a Nicoletti, Giovanni Francesco $u Plastic Surgery Unit, Department of Multidisciplinary Medical and Dental Specialties, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy
700    1_
$a Ferraro, Giuseppe Andrea $u Plastic Surgery Unit, Department of Multidisciplinary Medical and Dental Specialties, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy
700    1_
$a Schiraldi, Chiara $u Department of Experimental Medicine, Section of Biotechnology, Molecular Medicine and Medical Histology, University of Campania "L. Vanvitelli", 80138 Naples, Italy $1 https://orcid.org/000000021066843X
700    1_
$a Caraglia, Michele $u Department of Precision Medicine, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy $1 https://orcid.org/0000000324086091
700    1_
$a Amler, Evzen $u Institute of Biophysics, 2nd Faculty of Medicine, Charles University, V Uvalu 84, 15006 Prague, Czech Republic
700    1_
$a Stiuso, Paola $u Department of Precision Medicine, University of Campania "Luigi Vanvitelli", 80138 Naples, Italy $1 https://orcid.org/0000000150967488
773    0_
$w MED00184066 $t Pharmaceuticals (Basel, Switzerland) $x 1424-8247 $g Roč. 15, č. 6 (2022)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35745646 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20220718 $b ABA008
991    __
$a 20220720100047 $b ABA008
999    __
$a ind $b bmc $g 1816403 $s 1168248
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 15 $c 6 $e 20220608 $i 1424-8247 $m Pharmaceuticals $n Pharmaceuticals (Basel) $x MED00184066
LZP    __
$a Pubmed-20220718

Najít záznam

Citační ukazatele

Možnosti archivace